DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
e••••• T••••••••• I••
Drug Discovery & Developmentgroup grade Aon a schedule nowsponsor unattributed
Nothing material in the last 200 days. No dated change on record yet.
Principal held
at least $17.5M
sum of BDC pieces, a lower bound
Fair value
$18.0M
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
Jan 1, 2030
no dated debt inside 24 months
On the tape since
Jun 30, 2026
latest Jun 30, 2026
Events
1
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| H••••••• C••••••• I••• | $17.5M | 100¢ | new this quarter |
Every BDC piece · 2 positions across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| H••••••• C••••••• I••• | term loan first lien S••••• S••••••, J•••••• 2030, P•••• + 2.25%, F•••• rate 9.25%, Cap rate 10.25%, 5.95% E••• | $17.5M | $17.9M 100c | S+225 bp |
| H••••••• C••••••• I••• | warrants equity W••••••, 12/22/2023, C••••• S•••• | Not disclosed | $29,000 13c |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $17.5M | 100c | S+225 bp | Jan 1, 2030 | 1 |
Equity pieces beside the debt: warrants ($29,000 fair value, 1 BDC)
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $17.5M | $17.9M | 100c | 0 |
What changed
- New borrower on a BDC scheduleJun 30, 2026
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- E••••• T•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Drug Discovery & Developmentreportedas one filer wrote it